Q1 2025 Cyanotech Corp Earnings Call Transcript
Key Points
- Net sales increased by 15% compared to the prior year, driven by higher sales of astaxanthin.
- Launch of Hawaiian Spirulina gummies in May to complement existing product offerings.
- Operating loss decreased by $200,000 compared to the first quarter of fiscal 2024.
- Preliminary financing secured to meet market demand and support future growth.
- Positive outlook on consumer interest in sustainable, high-quality dietary supplements.
- Gross profit margin decreased by 4.8 percentage points due to higher costs from lower production volumes.
- Gross profit remained flat at $1.5 million despite increased sales.
- Net loss for the quarter was $1.2 million, slightly improved but still significant.
- Working capital decreased significantly from $2 million to $207,000.
- Reclassification of $1 million of debt from long term to short term, impacting financial flexibility.
Hello all from Kona, Hawaii. Thank you all for joining us today to report Cyanotech's first quarter fiscal year 2025 earnings results. I am Matt Custer, President and Chief Executive Officer of Cyanotech. Joining me on the call today is Felicia Ladin, our Chief Financial Officer. I will turn the call over to Felicia to provide our forward-looking statement.
Thanks, Matt. Our discussion today may include forward-looking statements. We do not undertake any obligation to update forward-looking statements either as a result of new information, future events, or otherwise. Our actual results may differ materially from what is described in these forward-looking statements.
Some of the factors that may cause results to differ are listed in our publicly filed documents. For additional information, we encourage you to review our 10-Q and fiscal year 2024 10-K report filed
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
